GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 221 filers reported holding GUARDANT HEALTH INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,312,730 | -17.3% | 111,841 | -0.1% | 0.04% | -4.8% |
| Q2 2023 | $4,004,201 | +58.2% | 111,943 | +3.5% | 0.04% | +44.8% |
| Q1 2023 | $2,531,833 | +19.0% | 108,198 | +38.2% | 0.03% | -6.5% |
| Q4 2022 | $2,127,737 | -47.4% | 78,312 | -7.0% | 0.03% | -40.4% |
| Q3 2022 | $4,042,000 | -82.2% | 84,215 | -43.3% | 0.05% | -53.2% |
| Q1 2021 | $22,686,000 | +32.7% | 148,614 | +12.0% | 0.11% | +14.4% |
| Q4 2020 | $17,096,000 | +6.1% | 132,648 | -7.9% | 0.10% | -32.2% |
| Q3 2020 | $16,107,000 | -21.9% | 144,094 | -44.9% | 0.14% | -47.0% |
| Q2 2020 | $20,611,000 | -61.7% | 261,722 | -66.1% | 0.27% | -46.4% |
| Q1 2020 | $53,774,000 | +82.9% | 772,624 | +105.3% | 0.50% | +8.9% |
| Q4 2019 | $29,405,000 | +48.4% | 376,307 | +21.2% | 0.46% | +31.5% |
| Q3 2019 | $19,820,000 | +9.1% | 310,519 | +47.6% | 0.35% | -1.1% |
| Q2 2019 | $18,167,000 | – | 210,431 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |